InsiderClue
Insiders · Profile

Frohlich Tom

Chief Executive Officer at Jade Biosciences. Filing since 16 May 2025. CIK 0001823925

Company
Date
Role
Action
Shares
Amount
Of holding
JBIO Jade Biosciences, Inc.
16 May 2025
Chief Executive Officer
Bought
6,000
$44.40K
opened
1 decision on file.